Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) General Counsel Karen Soares sold 52,500 shares of Clover Health Investments stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $3.80, for a total value of $199,500.00. Following the completion of the sale, the general counsel now directly owns 1,299,663 shares in the company, valued at approximately $4,938,719.40. The trade was a 3.88 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Clover Health Investments Trading Down 0.8 %
Shares of CLOV stock opened at $3.64 on Friday. The company has a market capitalization of $1.82 billion, a P/E ratio of -18.20 and a beta of 2.00. The business's 50 day moving average is $4.08 and its two-hundred day moving average is $3.62. Clover Health Investments, Corp. has a 12-month low of $0.61 and a 12-month high of $4.87.
Wall Street Analysts Forecast Growth
CLOV has been the topic of several analyst reports. Canaccord Genuity Group boosted their target price on Clover Health Investments from $4.20 to $4.50 and gave the company a "buy" rating in a research report on Monday, March 3rd. Craig Hallum initiated coverage on Clover Health Investments in a research report on Tuesday, December 17th. They set a "buy" rating and a $6.00 target price on the stock.
Check Out Our Latest Stock Analysis on Clover Health Investments
Hedge Funds Weigh In On Clover Health Investments
Hedge funds have recently bought and sold shares of the business. Concurrent Investment Advisors LLC purchased a new position in Clover Health Investments during the third quarter worth approximately $28,000. Sigma Planning Corp purchased a new position in Clover Health Investments during the third quarter worth approximately $29,000. Parallax Volatility Advisers L.P. purchased a new position in Clover Health Investments during the third quarter worth approximately $38,000. Triumph Capital Management purchased a new position in Clover Health Investments during the fourth quarter worth approximately $45,000. Finally, KBC Group NV acquired a new stake in Clover Health Investments during the third quarter worth $53,000. Hedge funds and other institutional investors own 19.77% of the company's stock.
About Clover Health Investments
(
Get Free Report)
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
